We are live on ! Find out more
Ninety One (UK)

Ninety One (UK) Portfolio holdings

AUM $44.7B
1-Year Est. Return 17.24%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+17.24%
3 Year Est. Return
+87.79%
5 Year Est. Return
+111.34%
10 Year Est. Return
+534.1%
AUM
$43.1B
AUM Growth
-$3.52B
Cap. Flow
+$51.7M
Cap. Flow %
0.12%
Top 10 Hldgs %
35.5%
Holding
275
New
50
Increased
77
Reduced
93
Closed
38

Top Sells

1
ICLR icon
Icon
ICLR
+$537M
2
MSFT icon
Microsoft
MSFT
+$501M
3
TKO icon
TKO Group
TKO
+$284M
4
AVGO icon
Broadcom
AVGO
+$237M
5
NVDA icon
NVIDIA
NVDA
+$226M

Sector Composition

1 Technology 27.04%
2 Financials 17.55%
3 Healthcare 12.74%
4 Communication Services 12.51%
5 Consumer Discretionary 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.05T
$482M 1.12%
524,221
-16,783
-3% -$17M
ADP icon
27
Automatic Data Processing
ADP
$102B
$480M 1.11%
2,363,827
-11,281
-0.5% -$2.59M
BSX icon
28
Boston Scientific
BSX
$65.4B
$459M 1.06%
7,308,540
+1,863,991
+34% +$149M
CVX icon
29
Chevron
CVX
$372B
$417M 0.97%
2,014,575
+1,596,929
+382% +$291M
SPGI icon
30
S&P Global
SPGI
$133B
$417M 0.97%
979,893
+58,861
+6% +$27.3M
J icon
31
Jacobs Solutions
J
$15.5B
$414M 0.96%
3,255,342
+99,029
+3% +$13.5M
CFG icon
32
Citizens Financial Group
CFG
$30.4B
$406M 0.94%
6,768,224
+193,510
+3% +$11.9M
AZN icon
33
AstraZeneca
AZN
$261B
$397M 0.92%
+2,047,019
New +$395M
AER icon
34
AerCap
AER
$23.1B
$386M 0.89%
2,810,328
+6,325
+0.2% +$905K
ALGN icon
35
Align Technology
ALGN
$12.6B
$382M 0.89%
2,228,214
+911
+0% +$160K
RACE icon
36
Ferrari
RACE
$66.2B
$368M 0.85%
1,104,106
+198,983
+22% +$69.6M
MCO icon
37
Moody's
MCO
$88.9B
$367M 0.85%
840,302
+4,440
+0.5% +$2.1M
CHKP icon
38
Check Point Software Technologies
CHKP
$14.2B
$366M 0.85%
2,562,679
+12,916
+0.5% +$2.16M
SNX icon
39
TD Synnex
SNX
$19.4B
$353M 0.82%
2,094,298
-134,793
-6% -$21.2M
CRH icon
40
CRH
CRH
$68.7B
$349M 0.81%
3,320,503
-125,316
-4% -$14.7M
TT icon
41
Trane Technologies
TT
$104B
$342M 0.79%
821,041
+146,811
+22% +$62.3M
GM icon
42
General Motors
GM
$68.9B
$337M 0.78%
4,529,367
-414,365
-8% -$32.9M
UBS icon
43
UBS Group
UBS
$173B
$332M 0.77%
8,687,978
-141,608
-2% -$6.06M
ABT icon
44
Abbott
ABT
$174B
$319M 0.74%
3,109,726
+421,444
+16% +$47.6M
TMO icon
45
Thermo Fisher Scientific
TMO
$198B
$313M 0.73%
637,262
-255,199
-29% -$138M
META icon
46
Meta Platforms (Facebook)
META
$1.63T
$303M 0.7%
528,841
+127,614
+32% +$81.8M
GS icon
47
Goldman Sachs
GS
$315B
$298M 0.69%
352,776
-135,168
-28% -$121M
NEE icon
48
NextEra Energy
NEE
$185B
$282M 0.65%
3,033,694
+1,131,633
+59% +$101M
FCX icon
49
Freeport-McMoran
FCX
$84.1B
$269M 0.62%
4,584,244
-59,796
-1% -$3.61M
FDS icon
50
Factset
FDS
$9.15B
$259M 0.6%
1,194,996
+20
+0% +$4.67K

Similar funds

Ninety One (UK)'s Q1 2026 Portfolio in Review

As of Q1 2026, Ninety One (UK) held 275 positions worth $43.1B, down 7.5% from $46.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ninety One (UK)'s Q1 2026 filing shows 50 new, 77 increased, 93 reduced and 38 closed positions. Its largest new stake was AstraZeneca: 2,047,019 shares worth $397M. The largest sale was Icon, an estimated $537M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • Ninety One (UK)'s largest Q1 2026 buy was AstraZeneca: 2,047,019 shares worth $397M.
  • Ninety One (UK) added most to Apple in Q1 2026, an estimated $538M increase.
  • Ninety One (UK)'s biggest Q1 2026 reduction was Microsoft, cutting an estimated $501M.
  • Ninety One (UK) fully exited Icon in Q1 2026, selling an estimated $537M.
  • Ninety One (UK)'s ten largest holdings make up 35% of its $43.1B portfolio in Q1 2026.
  • Ninety One (UK) opened 50 new positions and closed 38 in Q1 2026.
  • Ninety One (UK)'s portfolio value fell 7.5% quarter-over-quarter to $43.1B.

Based on Ninety One (UK)'s 13F filing for Q1 2026, filed 24 Apr 2026.